Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

550.54 +0.41 (+0.07%)
Official Closing Price Updated: 7:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,358,088
Open 548.81
Bid (Size) 548.50 (5)
Ask (Size) 550.45 (1)
Prev. Close 550.13
Today's Range 547.63 - 555.49
52wk Range 299.96 - 601.84
Shares Outstanding N/A
Dividend Yield 0.62%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend
Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today. 
Via InvestorPlace
'Stocks In Monopolistic Bull Market': Wall Street Analyst Contemplates A Bright Future For Next Phase
The analyst illustrated how the dominant force in stock market returns for 2023 has been the "Magnificent 7." 
Via Benzinga

Performance

YTD
+50.84%
+50.84%
1 Month
-0.51%
-0.51%
3 Month
+19.99%
+19.99%
6 Month
+63.79%
+63.79%
1 Year
+77.10%
+77.10%

More News

Read More
Are Wall Street Analysts Wrong About Eli Lilly Stock?
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Peering Into Eli Lilly's Recent Short Interest
Via Benzinga
Eli Lilly Unusual Options Activity
Via Benzinga
1 Growth Stock That Could Turn $1,000 Into $2,500 by 2030
Via The Motley Fool
The 7 Most Hated Stocks by Institutional Traders
Via InvestorPlace
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope
Via FinancialNewsMedia
Elon Musk-Backed Neuralink Starts Participant Enrollment For Paralysis, Eli Lilly Cracks Down on Counterfeit Weight Loss Drugs, Meta Looks to Capitalize on India's In-App Payment Surge: Today's Top Stories
Via Benzinga
Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 15 Years
Via Benzinga
2 Stocks That Moved the Market in August
Via The Motley Fool
Eli Lilly Cracks Down on Counterfeit Mounjaro Wight Loss and Diabetes Drugs, Sues Lawsuit Against Clinics
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise
Via FinancialNewsMedia
Topics Death Intellectual Property
Exposures Death Intellectual Property
Flee to Healthcare Stocks if Recession Rears its Head?
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Check Out What Whales Are Doing With LLY
Via Benzinga
3 Healthcare Stocks That Turned $100,000 Into $1 Million in 10 Years
Via The Motley Fool
Could Ely Lilly Be the Best Pharma Stock to Own Now and Forever?
Via MarketBeat
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Can These 3 Healthcare Dividend Stocks Deliver Income Growth?
Via MarketBeat
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 (Bad) Reasons to Avoid or Sell Novo Nordisk Stock
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Madrigal Pharmaceuticals Surges As Its NASH Treatment Toes The Long-Awaited Finish Line
Via Investor's Business Daily
Should You Still Buy the S&P 500's Best-Performing August Stocks?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.